Our previous shows were a great success! Next, the presence of femous speaker “Non Dorman” will make the event more lively that we believe!

We are getting high crowd. So, get your ticket before we are out of seat. Hurry!

Buy Tickets

Complimentary Drinks

Open Wi-Fi Facilities

Win a Macbook Pro (Raffle Draw)











  Saturday, September 18th  
  Plenary hall   Hall 2   Hall 3 Hall 4  
  7:10-7:55
Breakfast Symposium
7:10-7:55 Breakfast Session by EKFC   
 

   
 

Paediatric complement-driven renal diseases: pathophysiology and therapeutic advances

Estimating GFR from serum markers in 2021  
  Welcome and Introduction - Nicole van de Kar  Chair: Arend Bökenkamp
  A clinical approach to children with complement-driven renal diseases
- Marina Vivarelli

GFR estimation in children and adolescents - what is the optimal approach
Hans Pottel

  Iptacopan: an oral Factor B inhibitor in development for complement-driven renal diseases-Nicholas Webb Shrunken pore syndrome - fact or fiction?
Emil den Bakker
 
  Summary and Panel Q&A -Nicole van de Kar    
  8:00 -8:45 Keynote   
  Retarding progressive kidney failure - what paediatricians can learn from adult nephrologists
Jürgen Flöge
 
  09:00 - 10:45  Session 9
Details
09:00 - 10:45  Session 10
Details
09:00 - 10:45 Pitch Session 9
Details
Pitch Session 10
Details
 
  Pharmacotherapy Neurocognitive dysfunction in pediatric kidney disease Hypertension Transplantation 2  
  Chairs: Rukshana Shroff, Marsch Konigs  
  Chairs: Aysun Karabay Bayazıt, Antonia Bouts 09:00 - 09:25  State of the Art Chairs: Elke Wühl, Tomas Seeman Chairs: Priya Verghese, Sevcan Bakkaloğlu  
  Brain structure and function in children and adolescents with kidney failure - Sophie Lijdsman  
  09:00 - 09:25 State of the art 09:00 - 09:09 PI-89 PI-100  
  Immunosuppressive medication: to TDM or not to TDM
Teun van Gelder
09:25 - 09:50  State of the Art 09:09 - 09:18 PI-90 PI-101  
  Learning from disease models
Marsh Konigs
09:18 - 09:27 PI-91 PI-102  
  09:27 - 09:36 PI-92 PI-103  
  09:25 - 09:38 OP-22 09:50 - 10:05 Invited Lecture 09:36 - 09:45 PI-93 PI-104  
  09:38 - 09:51 OP-23 Kidney Fog: a patient's perspective
Vincent Moolenaar 
09:45 - 09:54 PI-94 PI-105  
  09:51 - 10:04 OP-24 09:54 - 10:03 PI-95 PI-106  
  10:04 - 10:17  OP-25 10:05 - 10:18  OP-26 10:03 -10:12 PI-96 PI-107  
  10:17 - 10:42 State of the art 10:18 -10:43 State of the Art 10:12 - 10:21 PI-97 PI-108  
  Draining the oedema: something old, something new, something for you
Detlef Bockenhauer
Are my kidneys bad for the brain?
Stephan Hooper 
10:21 - 10:30 PI-98 PI-109  
  10:30 - 10:39 PI-99 PI-110  
  10:45-11:15 BREAK  +  Live stream from the studio: "Green meets grey"  
  11:15 - 13:00  Session 11
Details
11:15 - 13:00  Session 12
Details
11:15 - 13:00 Pitch Session 11
Details
Pitch Session 12
Details
 
  What's new in dialysis Metabolic and stone disease Registry Nephrotic Syndrome 1  
  Chairs: Aleksandra Zurowska, Sevcan Bakkaloglu Chairs: Olivia Boyer, Michiel Oosterveld  
  11:15 - 11:40  State of the Art 11:15 - 11:40 State of the art Chairs: Jerome Harambat, Charlotte Bootsma Chairs: Femke Prince-Vrieling, Dorota Drozdz  
  Contemporary, optimized hemodialysis in children
Claus Schmitt
Methylmalonic acidemia: Kidney involvement, management and outcome
Matthias Baumgartner
  11:15 - 11:24 PI-111 PI-122 This abstract has been withdrawn  
  11:40 - 11:53 OP-27 11:24 - 11:33 PI-112 PI-123  
  11:53 - 12:06 OP-28 11:33 - 11:42 PI-113 PI-124  
  12:06 - 12:19  OP-29 11:47 - 12:00  OP-31 11:42 - 11:51 PI-114 PI-125  
  12:19 - 12:32  OP-30 12:00 - 12:13 OP-32 11:51 - 12:00 PI-115 PI-126  
  12:32 - 12:52 State of the Art 12:13 - 12:26 OP-33 12:00 - 12:09 PI-116 PI-127  
  Hemodialysis machines in 2021: manufacturers’ proposals versus children’s needs
Bruno Ranchin
12:26 -12:40  OP-34 12:09 - 12:18 PI-117 PI-128  
  12:40 - 13:00  Controversy 12:18 - 12:27 PI-118 PI-129  
  12:52 - 13:15 State of the Art

iRNA for ALL children with PH1?
Shabbir Moocchala vs. Justine Bacchetta

12:27 - 12:36 PI-119 PI-130  
 
What is possible by HD for children with respect of uremic toxin removal (joint discussion)  - Evelien Snauwaert
12:36 - 12:45 PI-120 PI-131  
  12:45 - 12:54 PI-121 PI-132  
  13:15-14:15 Lunch Symposium  13:15-14:15 Lunch Symposium  13:15-14:15 LUNCH  
   
   
  To understand the pathway of transition and treatment of patients with XLH from pediatric patient, to adolescent and finally adult Improving cystinosis transition patient adherence   
  Chair/Moderator: Jun Oh   
  Treatment of paediatric XLH patients and transition to adolescent
Wesley Hayes
Why is adherence in cystinosis transition patients such a problem?
o Coping with independence, o Psychosocial issues, o Communication issues
Detlef Böckenhauer
 
  Treatment of adolescent XLH patients and transition to adult
Volga Zhukouskaya
What can improve adherence?
o Patient/family education,  o Support,  o Role of the multidisciplinary team
Jun Oh
 
  Treatment of adult XLH patients
Martin H de Borst
A global adherence tool: the Cystinosis & Me app
o Purpose,  o Functionality,  o Availability
Detlef Böckenhauer
 
  Open Q&A session
All
o Multidisciplinary team evaluation
Ø Physician , Ø Nurse,  Ø Clinical psychologist
Jun Oh, Nicola Townsend, Fionna Bathgate
 
  Q&A  
  14:30 - 16:15  Session 13
Details
14:30 - 16:15  Session 14
Details
14:30 -16:15 Pitch Session 13
Details
Pitch Session 14
Details
 
  Cystic kidney disease Urinary tract infections Metabolic Disease Nephrotic Syndrome 2  
  Chairs: Max Liebau, Djalila Mekahli Chairs: Tomas Seeman, Joanna van Wijk Chairs: Marlies Cornelissen, Olivia Boyer Chairs: Gema Ariceta, Markus Kemper  
  14:30 - 14:55 State of the Art 14:30 - 14:55 State of the Art 14:30 - 14:39 PI-133 PI-144  
  Hypertension in cystic kidney diseases
Laura Massella
Defense against UTI beyond anatomy and urodynamics
Milan Chromek
14:39 - 14:48 PI-134 PI-145  
  14:48 - 14:57 PI-135 PI-146  
  14:55 - 15:20 State of the Art 14:57 - 15:06 PI-136 PI-147  
  14:55 - 15:08  OP-35 Indications for antibiotic prophylaxis in 2021
Kjell Tullus
15:06 - 15:15 PI-137 PI-148  
  15:08 - 15:21 OP-36 15:15 - 15:24 PI-138 PI-149  
  15:21 - 15:34 OP-37 15:24 - 15:33 PI-139 PI-150  
  15:34 - 15:47 OP-38 15:20 - 15:33 OP-39 15:33 - 15:42 PI-140 PI-151  
  15:47 - 16:12 State of the Art 15:33 - 15:46 OP-40 15:42 - 15:51 PI-141 PI-152  
  Prenatal detection of cystic kidney disease - what can we tell families? - Paul Winyard 15:46 - 15:59  OP-41 15:51 - 16:00 PI-142 PI-153  
  15:59 - 16:12 OP-42 16:00 - 16:09 PI-143 PI-154  
  16:15-16:45 BREAK +  Live stream from the studio: "Big Buximab"  
  16:45 - 18:30 Session 15
Details
16:45 - 18:30 Session 16
Details
16:45 - 18:30  Pitch Session 15
Details
Pitch Session 16
Details
 
  Electrolyte disorders  Artificial intelligence and telemedicine  Hereditary Disease UTI & Psychosocial Aspects  
  Chairs:Detlef Bockenhauer, Arend Bökenkamp  
  16:45 - 17:10  State of the Art Chairs: Franz Schaefer, Jun Oh Chairs: Huib de Jong, Djalila Mekhali Chairs: Ans van Wijk, Ann Raes  
  Potassium is good for you
Ewout Hoorn
 
  16:45 - 17:10 State of the Art 16:45 - 16:54 PI-155 PI-166  
  17:10 - 17:23 OP-43 Artificial Intelligence and Deep Learning in Nephropathology  - Jan Becker 16:54 - 17:03 PI-156 PI-167  
  17:23 - 17:36 OP-44 17:03 - 17:12 PI-157 PI-168  
  17:36 - 17:49  OP-45 17:10 - 17:23 OP-47 17:12 - 17:21 PI-158 PI-169  
  17:49 - 18:02 OP-46 17:23 - 17:36 OP-48 17:21 - 17:30 PI-159 PI-170  
  18:02- 18:11 Controversy 17:36 - 17:49  OP-49 17:30 - 17:39 PI-160 PI-171  
  Less is more: a case for dialling down the infusion rate
Milan Chromek
17:49 - 18:02 OP-50 17:39 - 17:48 PI-161 PI-172  
  18:02 - 18:27 State of the Art 17:48 - 17:57 PI-162 PI-173  
  18:11 - 18:27 Controversy Artificial intelligence for prediction and treatment AKI
Greet de Vlieger
17:57 - 18:06 PI-163 PI-174  
  Safety in sodium: a case for isotonic fluids (joint discussion) - Wesley Hayes 18:06 - 18:15 PI-164 PI-175  
  18:15 - 18:24 PI-165 PI-176  
  19:30-23:00  Social Dinner, separate registration required  
   

EVENT
SPONSORS